The revenue stands at ₹3,567.20 crore, reflecting a quarter-on-quarter *(QoQ) decrease of 3.52 per cent from ₹3,697.16 crore. This corresponds to a year-on-year *(YoY) growth of 11.52 per cent.
Operating Profit stands at ₹812.84 crore, reflecting a quarter-on-quarter *(QoQ) decrease of 11.78 per cent from ₹921.33 crore. This corresponds to a year-on-year *(YoY) decline of 0.39 per cent.
PBDT stands at ₹731.60 crore, reflecting a quarter-on-quarter *(QoQ) decrease of 13.51 per cent from ₹845.84 crore. This corresponds to a year-on-year *(YoY) growth of 7.25 per cent.
Profit Before Tax stands at ₹509.00 crore, reflecting a quarter-on-quarter *(QoQ) decrease of 18.43 per cent from ₹624.02 crore. This corresponds to a year-on-year *(YoY) growth of 2.83 per cent.
Net Profit stands at ₹413.88 crore, reflecting a quarter-on-quarter *(QoQ) decrease of 20.44 per cent from ₹520.18 crore. This represents a 7.64 per cent year-on-year *(YoY) growth for the same year.
in ₹ cr
in ₹ cr
in ₹ cr
in ₹ cr
| Company | 1 Day | 1 Week | 1 month | 3 month | 6 month | 1 Year |
|---|---|---|---|---|---|---|
| Mankind Pharma | 0.00% | 5.32% | 16.81% | 22.89% | 12.63% | -2.20% |
| Torrent Pharma. | -0.27% | 0.33% | 4.92% | 4.07% | 17.82% | 33.05% |
| Cipla | -0.35% | 10.42% | 16.09% | 7.34% | -6.54% | -4.36% |
| Dr Reddy's Labs | -0.57% | 4.66% | 7.88% | 3.87% | 6.34% | 9.07% |
| Lupin | -1.14% | 0.09% | -3.46% | 0.88% | 11.00% | 10.80% |
| Zydus Lifesci. | -1.98% | 6.49% | 5.86% | 9.86% | 6.53% | 8.76% |
| Aurobindo Pharma | -0.79% | 0.72% | 9.63% | 27.53% | 21.61% | 24.32% |
Chairman & Wholetime Director : RAMESH CHAND JUNEJA
Vice Chairman & Managing Director : RAJEEV JUNEJA
Whole Time Director & Chief Executive Officer : SHEETAL ARORA
Independent Director : TILOKCHAND PUNAMCHAND OSTWAL
Independent Director : Bharat Anand
Whole-time Director : SATISH KUMAR SHARMA
Independent Director : Vivek Kalra
Independent Director : Vijaya Sampath
Company Sec. & Compli. Officer : Hitesh Kumar Jain